| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-14 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.26 | 8e-07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |